CircRNA-Associated CeRNAs Regulatory Axes in Retinoblastoma: A Systematic Scoping Review.
CeRNA
circTET1
circ_0000034
circ_0000527
circular RNA
retinoblastoma
sponge
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
04
2022
accepted:
10
06
2022
entrez:
22
7
2022
pubmed:
23
7
2022
medline:
23
7
2022
Statut:
epublish
Résumé
Retinoblastoma (RB) is one of the most common childhood cancers caused by RB gene mutations (tumor suppressor gene in various patients). A better understanding of molecular pathways and the development of new diagnostic approaches may lead to better treatment for RB patients. The number of studies on ceRNA axes is increasing, emphasizing the significance of these axes in RB. Circular RNAs (circRNAs) play a vital role in competing endogenous RNA (ceRNA) regulatory axes by sponging microRNAs and regulating gene expression. Because of the broadness of ceRNA interaction networks, they may assist in investigating treatment targets in RB. This study conducted a systematic scoping review to evaluate verified loops of ceRNA in RB, focusing on the ceRNA axis and its relationship to circRNAs. This scoping review was carried out using a six-step strategy and the Prisma guideline, and it involved systematically searching the publications of seven databases. Out of 363 records, sixteen articles were entirely consistent with the defined inclusion criteria and were summarized in the relevant table. The majority of the studies focused on the circRNAs circ_0000527, circ_0000034, and circTET1, with approximately two-fifths of the studies focusing on a single circRNA. Understanding the many features of this regulatory structure may help elucidate RB's unknown causative factors and provide novel molecular potential therapeutic targets and medical fields.
Identifiants
pubmed: 35865469
doi: 10.3389/fonc.2022.910470
pmc: PMC9294360
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
910470Informations de copyright
Copyright © 2022 Asadi, Moslehian, Sabaie, Sharifi-Bonab, Hakimi, Hussen, Taheri, Rakhshan and Rezazadeh.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12080-12092
pubmed: 33336726
Cell Rep. 2015 Jan 6;10(1):103-11
pubmed: 25543144
RNA Biol. 2017 Aug 3;14(8):992-999
pubmed: 27617908
Neurochem Res. 2020 Nov;45(11):2691-2702
pubmed: 32865704
Int J Oncol. 2004 Jul;25(1):87-95
pubmed: 15201993
Mol Cancer. 2020 May 9;19(1):86
pubmed: 32386516
Mol Cell. 2014 Oct 2;56(1):55-66
pubmed: 25242144
Nat Struct Mol Biol. 2015 Mar;22(3):256-64
pubmed: 25664725
Int J Mol Sci. 2019 Aug 13;20(16):
pubmed: 31412535
Exp Lung Res. 2016 Aug;42(6):286-95
pubmed: 27462913
Cells. 2021 Nov 30;10(12):
pubmed: 34943882
Curr Eye Res. 2022 Apr;47(4):624-633
pubmed: 34963405
Anticancer Drugs. 2021 Jun 1;32(6):635-646
pubmed: 33595945
RNA. 2015 Feb;21(2):172-9
pubmed: 25449546
Front Mol Biosci. 2020 Oct 28;7:577938
pubmed: 33195421
Int J Mol Sci. 2014 May 26;15(6):9331-42
pubmed: 24865493
Bioengineered. 2020 Dec;11(1):949-957
pubmed: 32892696
Am J Cancer Res. 2017 Jul 01;7(7):1566-1576
pubmed: 28744405
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5043-8
pubmed: 11309491
Cancer Res. 2006 Sep 1;66(17):8477-83
pubmed: 16951159
BMC Genomics. 2015;16 Suppl 7:S8
pubmed: 26099335
Oncogene. 2003 Nov 24;22(53):8590-607
pubmed: 14634621
Oncogene. 2018 Mar;37(12):1551-1560
pubmed: 29321667
RNA. 1998 Sep;4(9):1047-54
pubmed: 9740124
Mol Cell. 2017 Apr 6;66(1):22-37.e9
pubmed: 28344082
Cancers (Basel). 2020 Mar 16;12(3):
pubmed: 32187976
Nature. 2010 Jun 24;465(7301):1033-8
pubmed: 20577206
Cell Res. 2015 Aug;25(8):981-4
pubmed: 26138677
Oncogene. 2010 Mar 4;29(9):1351-61
pubmed: 20010874
Nat Commun. 2021 Jan 12;12(1):295
pubmed: 33436560
Curr Eye Res. 2021 Nov;46(11):1751-1761
pubmed: 33988065
Mol Cancer. 2020 Nov 10;19(1):157
pubmed: 33172486
Steroids. 2005 Oct;70(11):770-4
pubmed: 16024059
Cell Death Dis. 2021 May 11;12(5):468
pubmed: 33976116
Cell Death Dis. 2021 Mar 19;12(4):297
pubmed: 33741901
Nat Commun. 2016 Apr 06;7:11215
pubmed: 27050392
Curr Eye Res. 2022 Jan;47(1):115-126
pubmed: 34823425
Cell. 2014 Sep 25;159(1):134-147
pubmed: 25242744
Biomed Pharmacother. 2018 Sep;105:326-333
pubmed: 29864621
Arch Ophthalmol. 2002 Sep;120(9):1232-3
pubmed: 12215105
PeerJ. 2020 Sep 25;8:e10032
pubmed: 33033662
J Exp Clin Cancer Res. 2018 Dec 27;37(1):325
pubmed: 30591054
Nat Commun. 2017 Mar 30;8:14741
pubmed: 28358055
PLoS Genet. 2013;9(9):e1003777
pubmed: 24039610
J Exp Clin Cancer Res. 2020 Aug 15;39(1):160
pubmed: 32799891
Pigment Cell Melanoma Res. 2011 Feb;24(1):197-206
pubmed: 20883453
Biomed Rep. 2015 Mar;3(2):152-158
pubmed: 25798239
Onco Targets Ther. 2020 Apr 03;13:2873-2886
pubmed: 32308420
Cell Cycle. 2008 Nov 1;7(21):3294-301
pubmed: 18948735
Nucleic Acids Res. 2016 Apr 7;44(6):2846-58
pubmed: 26861625
Adv Exp Med Biol. 2016;927:1-47
pubmed: 27376730
Mol Cancer. 2019 Oct 17;18(1):144
pubmed: 31623606
Curr Eye Res. 2021 Jul;46(7):978-987
pubmed: 33108919
J Hematol Oncol. 2019 Oct 17;12(1):103
pubmed: 31623653
Curr Eye Res. 2021 Sep;46(9):1414-1423
pubmed: 33629639
Oncogene. 2018 Feb 1;37(5):555-565
pubmed: 28991235
Chin J Cancer. 2011 Mar;30(3):204-12
pubmed: 21352698
EMBO Rep. 2012 Oct;13(10):900-8
pubmed: 22964758
Mol Cell Biochem. 2016 Apr;415(1-2):183-96
pubmed: 26992905
J Biol Chem. 2009 Feb 27;284(9):5731-41
pubmed: 19073608
Cell Rep. 2015 Aug 11;12(6):922-36
pubmed: 26235627
Blood. 2008 Apr 1;111(7):3322-30
pubmed: 18362212
Mol Cancer. 2021 Apr 9;20(1):66
pubmed: 33836754
Cell Death Differ. 2019 Jul;26(7):1346-1364
pubmed: 30341421
Nat Genet. 2007 Aug;39(8):1033-7
pubmed: 17643101
J Gastroenterol Hepatol. 2022 Jun;37(6):1107-1118
pubmed: 35434854
Oncotarget. 2017 May 22;8(40):67169-67180
pubmed: 28978024
J Hematol Oncol. 2017 Feb 20;10(1):52
pubmed: 28219405
Biochim Biophys Acta. 2012 Jan;1825(1):11-7
pubmed: 21963805
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Oncol Lett. 2017 Dec;14(6):6708-6714
pubmed: 29391877
Clin Cancer Res. 2017 Jul 15;23(14):3918-3928
pubmed: 28174233
Clin Chim Acta. 2015 Apr 15;444:132-6
pubmed: 25689795
Biomed Res Int. 2021 Apr 01;2021:6614591
pubmed: 33869627
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10231-6
pubmed: 12925736
Front Aging Neurosci. 2021 Nov 25;13:742242
pubmed: 34899268
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
pubmed: 5279523
Cell Biochem Funct. 2020 Dec;38(8):1036-1046
pubmed: 32266733
Ophthalmology. 1993 Feb;100(2):216-24
pubmed: 8437830
Cell Res. 2017 May;27(5):626-641
pubmed: 28281539
Pathol Res Pract. 2021 Aug;224:153494
pubmed: 34091391
Nature. 2017 Apr 6;544(7648):115-119
pubmed: 28355180
Chin J Cancer. 2015 Sep 14;34(12):554-62
pubmed: 26369691
Exp Mol Pathol. 2021 Jun;120:104637
pubmed: 33844975
Nature. 2008 Sep 4;455(7209):58-63
pubmed: 18668040
Hum Cell. 2021 Jan;34(1):219-228
pubmed: 33058028
Brief Bioinform. 2017 Nov 1;18(6):984-992
pubmed: 27543790
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Genome Res. 2016 Sep;26(9):1277-87
pubmed: 27365365
Cancer Res. 2022 Jan 1;82(1):75-89
pubmed: 34753774
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Nature. 2013 Mar 21;495(7441):333-8
pubmed: 23446348
Cancer Res. 2017 May 1;77(9):2339-2350
pubmed: 28249903
J Natl Cancer Inst. 2018 Mar 1;110(3):
pubmed: 28903484
Oncotarget. 2016 Apr 12;7(15):19693-708
pubmed: 26930713
Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11324-9
pubmed: 9736735
Mol Cell Biochem. 2021 Jan;476(1):69-80
pubmed: 32844346
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Genome Biol. 2014 Jul 29;15(7):409
pubmed: 25070500
Front Cell Dev Biol. 2021 Sep 13;9:714330
pubmed: 34589484
Exp Eye Res. 2021 May;206:108529
pubmed: 33676964
Wiley Interdiscip Rev RNA. 2022 Jan;13(1):e1685
pubmed: 34342387
Cell Death Dis. 2018 Feb 7;9(2):175
pubmed: 29415990
Cell Death Dis. 2020 Sep 23;11(9):788
pubmed: 32968054
Mol Cancer. 2019 Jan 21;18(1):13
pubmed: 30665425
Biomed Pharmacother. 2018 Nov;107:598-605
pubmed: 30114643
Arch Ophthalmol. 1996 Nov;114(11):1348-56
pubmed: 8906025
Int J Oncol. 2011 Jan;38(1):219-25
pubmed: 21109943
Int J Mol Sci. 2019 May 09;20(9):
pubmed: 31075975
Cell Death Dis. 2018 Aug 6;9(8):838
pubmed: 30082829
Dig Liver Dis. 2020 Dec;52(12):1494-1502
pubmed: 32807692
Am J Hematol. 2003 Aug;73(4):230-5
pubmed: 12879424
Exp Eye Res. 2021 Oct;211:108650
pubmed: 34102206
Biomed Res Int. 2016;2016:1579490
pubmed: 27642589
N Engl J Med. 2008 Jan 31;358(5):502-11
pubmed: 18234754
Mol Cancer. 2021 Oct 25;20(1):138
pubmed: 34696797
Turk J Ophthalmol. 2015 Dec;45(6):259-267
pubmed: 27800245
RNA Biol. 2017 Mar 4;14(3):361-369
pubmed: 28080204
Cancer Cell Int. 2020 Jul 10;20:301
pubmed: 32669977
Cancer Lett. 2017 Dec 1;410:1-11
pubmed: 28923399
Int Ophthalmol Clin. 2008 Spring;48(2):135-47
pubmed: 18427266
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Genes Dev. 2009 Aug 1;23(15):1743-8
pubmed: 19574298
Mol Cancer. 2021 Aug 12;20(1):101
pubmed: 34384442
Mol Cell. 2018 Aug 2;71(3):428-442
pubmed: 30057200
Sci Rep. 2015 Jan 27;5:8057
pubmed: 25624062
Mol Cell. 2017 Apr 6;66(1):9-21.e7
pubmed: 28344080
PLoS One. 2014 Mar 07;9(6):e90859
pubmed: 24609083
PLoS One. 2016 Mar 21;11(3):e0151753
pubmed: 26998750
J Clin Lab Anal. 2021 Jun;35(6):e23727
pubmed: 33830559
Crit Rev Biochem Mol Biol. 2017 Apr;52(2):220-233
pubmed: 28095716
Biochim Biophys Acta Mol Cell Res. 2021 Apr;1868(5):118983
pubmed: 33549704
Eur Heart J. 2017 May 07;38(18):1402-1412
pubmed: 26873092
Cancer Lett. 2017 Mar 1;388:208-219
pubmed: 27986464
J Cell Biochem. 2018 Jan;119(1):440-446
pubmed: 28608528
Front Genet. 2019 Oct 11;10:940
pubmed: 31681407
Cancer Res Treat. 2015 Oct;47(4):844-52
pubmed: 25687862
RNA Biol. 2017 Aug 3;14(8):1035-1045
pubmed: 27982727
Int J Oncol. 2016 Nov;49(5):2105-2115
pubmed: 27666391
Clin Cancer Res. 2010 Jun 15;16(12):3240-52
pubmed: 20413433
J Int Soc Sports Nutr. 2016 Mar 01;13:8
pubmed: 26937223
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1649-54
pubmed: 15668399
Oncol Rep. 2014 Nov;32(5):2159-67
pubmed: 25199998
Dis Model Mech. 2016 Dec 1;9(12):1483-1495
pubmed: 27799148
Oncogene. 2003 Apr 24;22(16):2443-51
pubmed: 12717421
Nat Commun. 2019 May 3;10(1):2059
pubmed: 31053718
Int Ophthalmol. 2022 Feb;42(2):509-523
pubmed: 34633608
Bioengineered. 2021 Dec;12(1):8690-8697
pubmed: 34635012
J Cell Biochem. 2020 Jan;121(1):322-331
pubmed: 31297892
Trends Cell Biol. 2014 Jul;24(7):400-6
pubmed: 24698685
Nat Methods. 2007 Sep;4(9):721-6
pubmed: 17694064
Clin Breast Cancer. 2020 Oct;20(5):422-430
pubmed: 32741666
Brief Funct Genomics. 2017 Mar 1;16(2):80-86
pubmed: 26874353
Ann Transl Med. 2021 Aug;9(15):1236
pubmed: 34532373
Br J Cancer. 2014 Sep 9;111(6):1188-200
pubmed: 25010867
World J Gastroenterol. 2019 Sep 21;25(35):5300-5309
pubmed: 31558874
Brief Bioinform. 2020 Mar 23;21(2):441-457
pubmed: 30715152
Cancer Res. 2009 Mar 15;69(6):2185-90
pubmed: 19276350
Nat Commun. 2017 Oct 27;8(1):1149
pubmed: 29074849
Cell Death Dis. 2016 Jan 28;7:e2073
pubmed: 26821068
Aging (Albany NY). 2020 Jul 8;12(13):13338-13353
pubmed: 32644049
Proc Natl Acad Sci U S A. 1976 Nov;73(11):3852-6
pubmed: 1069269
Int J Biochem Cell Biol. 2020 Sep;126:105798
pubmed: 32629026
Mol Cell. 2013 Sep 26;51(6):792-806
pubmed: 24035497
Biochem Biophys Res Commun. 2016 Apr 29;473(2):600-6
pubmed: 27033599
Cancer Med. 2020 Jun;9(12):4360-4370
pubmed: 32347652